Skip to main content

Table 1 Survival of animals treated with or without intratumoral anti-C1-INH in the intracranial setting, with or without radiotherapy

From: Combined anti-C1-INH and radiotherapy against glioblastoma

Treatment (number of animals per group)

Survival (median days ± SD)

Controls (n = 6)

22 ± 2

Anti-C1-INH intratumorally (n = 6)

23 ± 2

RT 8 Gy × 2 (n = 6)

35 ± 4

RT 8 G × 2 + anti-C1-INH intratumorally (n = 5)

29 ± 6